Bellicum Pharmaceuticals is a biopharma company developing novel cellular immunotherapies for various forms of cancer (both hematological and solid tumors), as well as orphan inherited blood disorders.
Bellicum – dendritic cell vaccines
Cellectis is a biotech company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART).
Cellectis – gene-editing
Medigene is a biotech company focusing on the development of personalized T-cell immunotherapies. Medigene develops highly innovative treatment platforms concentrating on haematological malignancies, cancer and autoimmune diseases.